Trial intelligence / Profile preview

BIG LEAP: Degludec vs Aspart Pump Basal in T1D

NCT04409587Phase 4Completed

Sponsor
Mountain Diabetes and Endocrine Center
Start
Apr 2018
Primary completion
May 2020
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 4 trial of insulin degludec in type 1 diabetes mellitus (T1D), sponsored by Mountain Diabetes and Endocrine Center. Started Apr 2018; status: completed.

02

Drugs

insulin degludec
03

Conditions

type 1 diabetes mellitus (T1D)

Beyond the preview

Go deeper on NCT04409587.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04409587.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call